Corient Private Wealth LLC Lowers Stock Position in Avantor, Inc. $AVTR

Corient Private Wealth LLC cut its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 82.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 624,623 shares of the company’s stock after selling 2,881,330 shares during the period. Corient Private Wealth LLC’s holdings in Avantor were worth $7,158,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. Private Trust Co. NA increased its holdings in shares of Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after acquiring an additional 875 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Avantor by 28.1% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after purchasing an additional 905 shares in the last quarter. Osaic Holdings Inc. boosted its position in Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares in the last quarter. UMB Bank n.a. grew its stake in Avantor by 17.6% in the fourth quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock valued at $84,000 after purchasing an additional 1,101 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its stake in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Avantor

In other news, Director Simon Dingemans purchased 25,000 shares of the company’s stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the purchase, the director owned 25,000 shares in the company, valued at $203,500. This trade represents a ? increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gregory T. Lucier acquired 10,000 shares of Avantor stock in a transaction dated Friday, May 8th. The stock was purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the completion of the purchase, the director owned 60,000 shares of the company’s stock, valued at approximately $499,200. The trade was a 20.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.28% of the stock is owned by corporate insiders.

Avantor Stock Up 4.0%

AVTR stock opened at $10.07 on Friday. The stock has a market capitalization of $6.88 billion, a PE ratio of -12.44, a price-to-earnings-growth ratio of 5.62 and a beta of 0.97. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a 50 day moving average of $8.67 and a 200 day moving average of $9.49.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.54 billion. During the same quarter last year, the company posted $0.23 earnings per share. The business’s quarterly revenue was up .0% on a year-over-year basis. Sell-side analysts forecast that Avantor, Inc. will post 0.79 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on AVTR. Wall Street Zen cut shares of Avantor from a “buy” rating to a “hold” rating in a report on Saturday, May 30th. Wolfe Research cut shares of Avantor to an “underperform” rating and set a $7.00 target price for the company. in a research report on Monday, June 1st. Barclays lifted their price target on shares of Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday. Citigroup decreased their price objective on Avantor from $11.00 to $9.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. Finally, Royal Bank Of Canada began coverage on Avantor in a research note on Thursday, May 14th. They set a “sector perform” rating and a $9.00 target price on the stock. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Reduce” and an average target price of $10.47.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.